Maybe they'll raise after the Ovarian test is validated with the reduced peptides.
One would expect or hope they would be starting to line up the co who are going to use it as a LDT.
Thermo would have to be at the front of the queue surely?
Imagine what any deal with them would do to the sp.
I suspect BD1 will have instos throwing money at them when the time comes.
My worry is current shareholders may not get a look in.
Ann: Appendix 4D and Half-year financial report, page-28
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.53M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 49.0¢ | 47.5¢ | $31.30K | 65.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19549 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 33174 | 3 |
View Market Depth
| Last trade - 15.54pm 10/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |